A new Cedars Sinai Physician Associated Study used the processes and care of Daybreak to evaluate a dentist-led, ...

When the NHS recognised ADHD in adults in 2008, never in my wildest hypochondriacal dreams did I imagine it applied to me. I ...

BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% median reduction in the number of absence seizure ≥3s, p = 0.012DEE: 63.3% ...

Marius Pharmaceuticals, Inc. today announced the company will initiate a new post-marketing clinical study for potential label expansion evaluating KYZATREX® (testosterone undecanoate) CIII capsules ...

Professor Johan Verbraecken, shares insights on a recent ERS consensus statement on advanced telemedicine in obstructive ...

INGREZZA showed a nearly two-fold higher VMAT2 occupancy, consistent with greater potency when compared to AUSTEDO XR (deutetrabenazine) after a single ...

Sparrow Pharmaceuticals, a targeted cardiometabolic therapeutics company, today announced that the first patient has been enrolled in its new Phase 2b clinical trial ( CAPTAIN-T2D, NCT07296484) ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By ...

A new study analyzed the sleep patterns of jellyfish and sea anemones and found they share some sleep traits with humans. The ...

Randomized trial shows resolution of about half of cases, on par with intranasal steroids ...

The CASTLE Online Sleep Intervention may help reduce sleep onset latency for children with epilepsy when paired with standard ...

(HealthDay News) — A multimodal sleep foundation model based on polysomnography data can predict the risk for multiple conditions, including death, dementia, and myocardial infarction (MI), according ...